Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: A 12-month retrospective review

Journal of Glaucoma

Volumn 23, Issue 9, 2014, Pages 649-652

  Johnson, Matthew S ^a   Sarkisian, Steven R ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Adjuvants in trabeculectomy; Mitomycin C; Ologen; Trabeculectomy

Indexed keywords

DEXAMETHASONE; MITOMYCIN; NEOMYCIN; POLYMYXIN B; PREDNISOLONE ACETATE; ALKYLATING AGENT; COLLAGEN; COLLAGEN-GLYCOSAMINOGLYCAN COPOLYMER; GLYCOSAMINOGLYCAN;

AGED; ARTICLE; CHOROID HEMORRHAGE; CLINICAL ARTICLE; COLLAGEN IMPLANT; CONTROLLED STUDY; EVENING DOSAGE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; NONVALVED OPHTHALMIC DRAINAGE DEVICE; OUTCOME ASSESSMENT; TRABECULECTOMY; VISUAL ACUITY; WOUND HEALING; COMPARATIVE STUDY; DRUG EFFECTS; FEMALE; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OCULOPLETHYSMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALKYLATING AGENTS; COLLAGEN; COMBINED MODALITY THERAPY; FEMALE; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANTS; GLYCOSAMINOGLYCANS; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MITOMYCIN; RETROSPECTIVE STUDIES; TONOMETRY, OCULAR; TRABECULECTOMY; WOUND HEALING;

EID: 84918781098     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0000000000000018     Document Type: Article

References (13)

1. Reibaldi A, Uva MG, Longo A. Nine-year follow-up of trabeculectomy with or without low-dosage mitomycin-c in primary open-angle glaucoma. Br J Ophthalmol. 2008;92: 1666-1670.
2. Wilkins M, Indar A, Wormald R. Intraoperative mitomycin C for glaucoma surgery. Cochrane Database of Systematic Reviews. 2005, Issue 4.
3. Mietz H, Brunner R, Addicks K, et al. Histopathology of an avascular filtering bleb after trabeculectomy with mitomycin-C. J Glaucoma. 1993;2:2266-2270.
4. Debry PW, Perkins TW, Heatly G, et al. Incidence of lateonset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120:297-300.
5. Greenfield DS, Liebmann JM, Jee J, et al. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol. 1998; 116:443-447.
6. Jampel HD, Solus JF, Tracey PA, et al. Outcomes and blebrelated complications of trabeculectomy. Ophthalmology. 2012; 119:712-722.
7. Chen HS, Ritch R, Krupin T, et al. Control of filtering belb structure through tissue bioengineering: an animal model. Invest Ophthalmol Vis Sci. 2006;47:5310-5314.
8. Hsu WC, Ritch R, Krupin T, et al. Tissue bioengineering for surgical bleb defects: an animal study. Graefes Arch Clin Exp Ophthalmol. 2008;246:709-717.
9. Rosentreter A, Schild AM, Jordan JF, et al. A prospective randomized trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma. Eye. 2010;24: 1449-1457.
10. Boey PY, Narayanaswamy A, Aheng C, et al. Imaging of blebs after phacotrabeculectomy with Ologen collagen matrix implants. Br J Ophthalmol. 2011;95:340-344.
11. Papaconstantinou D, Georgalas I, Karmiris E, et al. Trabeculectomy with OloGen vs trabeculectomy for the treatment of glaucoma: a pilot study. Acta Ophthalmol. 2010;88:80-85.
12. Cillino S, Di Pace F, Cillino G, et al. Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial. Eye. 2011;25: 1598-1606.
13. Maris PJ, Ishida K, Netland PA. Comparison of trabeculectomy with Ex-PRESS miniature glaucoma device implanted under sclera flap. J Glaucoma. 2007;16:14-19.